State Street Corp Anixa Biosciences Inc Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Anixa Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 111,900 shares of ANIX stock, worth $374,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,900
Previous 108,500
3.13%
Holding current value
$374,865
Previous $338,000
26.92%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANIX
# of Institutions
53Shares Held
5.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.67 Million0.0% of portfolio
-
D.A. Davidson & Co.736KShares$2.47 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC604KShares$2.02 Million0.19% of portfolio
-
Ubs Group Ag531KShares$1.78 Million0.0% of portfolio
-
Mission Wealth Management, LP502KShares$1.68 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $103M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...